IgM autoantibodies to oxidized LDL
proteinIgM autoantibodies to oxidized LDL exert atheroprotective effects by suppressing pro-inflammatory immune responses to atherogenic LDL oxidation.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleAtheroprotective immune response counteracting pro-inflammatory IgG response to OxLDL.
Also acts inLipid entry/oxidation
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(1)
- Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.Minerva cardioangiologica · 2007 · PMID 18091649